Cited by 2,343Chemokine receptors and signalingProtease and Inhibitor MechanismsMechanisms of cancer metastasis

The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.

Cancer and the chemokine network

Balkwill, Fran·2004·Nature Reviews Cancer

DOI 10.1038/nrc1388

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/nrc1388

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citation
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Chemokines
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605

Flagged first, then by citations

Show all 102 references

1 of the 102 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Darash-Yahana, M. et al. Human prostate cancer growth, vascularisation and metastasis is stimulated via high expression levels of the chemokine receptor CXCR4. Proc. Am. Assoc. Cancer Res. 44, 789 (2003).

Sorted by citations

Items 301–400 of 1,000

The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients
Yaal‐Hahoshen, N., Shina, S., Leider–Trejo, L., Barnea, I., Shabtai, E. L., Azenshtein, E., Greenberg, I., Keydar, I., & Ben‐Baruch, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0074 · Cited by 149
VEGF/NRP-1 axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin
Luo, M., Hou, L., Li, J., Shao, S. H., Huang, S., Du, M., Liu, L., Lu, F., Xia, P., Qin, T., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.010 · Cited by 150
Cross talk Initiated by Endothelial Cells Enhances Migration and Inhibits Anoikis of Squamous Cell Carcinoma Cells through STAT3/Akt/ERK Signaling
Neiva, K. G., Zhang, Z., Miyazawa, M., Warner, K. A., Karl, E., & Nor, J. E. (2009) · Neoplasia · doi:10.1593/neo.09266 · Cited by 155
Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models
Peng, S.-B., Zhang, X., Paul, D. C., Kays, L. M., Gough, W. H., Stewart, J. A., Uhlik, M. T., Chen, Q., Hui, Y., Zamek‐Gliszczynski, M. J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0850 · Cited by 150
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Huck, B. R., Kötzner, L., & Urbahns, K. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707816 · Cited by 154
The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
Ning, Y., LaBonte, M. J., Zhang, W., Bohanes, P. O., Gerger, A., Yang, D., Benhaïm, L., Páez, D., Rosenberg, D. O., Venkata, K. C. N., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0915 · Cited by 148
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors
Nibbs, R. J. B., Gilchrist, D. S., King, V., Ferra, A., Forrow, S., Hunter, K. D., & Graham, G. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30068 · Cited by 148
Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3
Schaller, T. H., Batich, K. A., Suryadevara, C. M., Desai, R. R., & Sampson, J. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1384313 · Cited by 142
The multifaceted link between inflammation and human diseases
Rajendran, P., Chen, Y., Chen, Y., Chung, L.-C., Tamilselvi, S., Shen, C.-Y., Day, C. H., Chen, R., Viswanadha, V. P., Kuo, W., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26479 · Cited by 157
Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis
Wilson, J. M., Coletta, P. L., Cuthbert, R. J., Scott, N. A., MacLennan, K., Hawcroft, G., Leng, L., Lubetsky, J. B., Jin, K. K., Lolis, E., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.061 · Cited by 146
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
Narayan, G., Goparaju, C. M. V., Arias‐Pulido, H., Kaufmann, A. M., Schneider, A., Dürst, M., MANSUKHANI, M. M., Pothuri, B., & Murty, V. V. V. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-16 · Cited by 147
Tumor‐derived tumor necrosis factor‐alpha promotes progression and epithelial‐mesenchymal transition in renal cell carcinoma cells
Chuang, M., Sun, K., Tang, S., Deng, M., Wu, Y., Sung, J.-S., Cha, T., & Sun, G. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00756.x · Cited by 146
Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine
Omid Veiseh, A., Kievit, F. M., Ellenbogen, R. G., & Zhang, M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.010 · Cited by 149
The theory of tumor ecosystem
Chen, X., & Song, E. (2022) · 癌症：英文版 · doi:10.1002/cac2.12316 · Cited by 151
Generalized serial dilution module for monotonic and arbitrary microfluidic gradient generators
Lee, K., Kim, C., Ahn, B., Panchapakesan, R., Full, A. R., Nordee, L., Kang, J. Y., & Oh, K. W. (2008) · Lab on a Chip · doi:10.1039/b813582g · Cited by 147
The role of chemokines in intestinal inflammation and cancer
Wang, D., DuBois, R. N., & Richmond, A. J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.003 · Cited by 145
Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer
Goodell, V., Salazar, L. G., Urban, N. D., Drescher, C. W., Gray, H. J., Swensen, R. E., McIntosh, M. W., & Disis, M. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2813 · Cited by 149
Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review
van Baal, J. O. A. M., Noorden, C. J. F. V., Nieuwland, R., de Vijver, K. K. V., Sturk, A., van Driel, W. J., Kenter, G. G., & Lok, C. A. R. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417742897 · Cited by 145
G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 151
Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
Bhat, A. A., Nisar, S., Maacha, S., Carneiro-Lobo, T., Akhtar, S., Siveen, K. S., Wani, N. A., Rizwan, A., Bagga, P., Singh, M. K., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01294-3 · Cited by 145
Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential
Wang, J., Ou, Z.-L., Hou, Y.-F., Luo, J.-M., Shen, Z.-Z., Ding, J., & Shao, Z.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209703 · Cited by 145
Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4
Kofuku, Y., Yoshiura, C., Ueda, T., Terasawa, H., Hirai, T., Tominaga, S., Hirose, M., Maeda, Y., Takahashi, H. K., Terashima, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024851 · Cited by 157
The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
Darash-Yahana, M., Gillespie, J. W., Hewitt, S. M., Chen, Y.-Y. K., Maeda, S., Stein, I., Singh, S. P., Bedolla, R. B., Peled, A., Troyer, D. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006695 · Cited by 143
Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells
Brown, C. E., Vishwanath, R. P., Aguilar, B., Starr, R., Najbauer, J., Aboody, K. S., & Jensen, M. C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3332 · Cited by 143
Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer
Campbell, L. M., Maxwell, P. J., & Waugh, D. J. J. (2013) · Pharmaceuticals · doi:10.3390/ph6080929 · Cited by 145
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles
Yousefi, M., Dehghani, S., Nosrati, R., Ghanei, M., Salmaninejad, A., Rajaie, S., Hasanzadeh, M., & Pasdar, A. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00513-9 · Cited by 146
A Synthetic Biology Approach Reveals a CXCR4-G 13 -Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells
Yagi, H., Tan, W., Dillenburg-Pilla, P., Armando, S., Amornphimoltham, P., Simaan, M., Weigert, R., Molinolo, A., Bouvier, M., & Gutkind, J. S. (2011) · Science Signaling · doi:10.1126/scisignal.2002221 · Cited by 144
Targeting inflammatory pathways for tumor radiosensitization
Deorukhkar, A., & Krishnan, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.039 · Cited by 143
Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells
Chua, A. W. L., Hay, H. S., Rajendran, P., Shanmugam, M. K., Li, F., Bist, P., Koay, E. S.-C., Lim, L. H. K., Kumar, A. P., & Sethi, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.045 · Cited by 140
Association of Activated Transcription Factor Nuclear Factor κB With Chemoradiation Resistance and Poor Outcome in Esophageal Carcinoma
Izzo, J. G., Malhotra, U., Wu, T., Ensor, J., Luthra, R., Lee, J. H., Swisher, S. G., Liao, Z. X., Chao, K. S. C., Hittelman, W. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8810 · Cited by 140
The expanding role for small molecules in immuno-oncology
Offringa, R., Kötzner, L., Huck, B. R., & Urbahns, K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00538-9 · Cited by 140
CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
Biswas, S., Sengupta, S., Chowdhury, S. R., Jana, S., Mandal, G., Mandal, P., Saha, N., Malhotra, V., Gupta, A., Kuprash, D. V., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2811-8 · Cited by 139
Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells
Bruserud, Ø., Ryningen, A., Olsnes, A. M., Stordrange, L., Oyan, A. M., Kalland, K. H., & Gjertsen, B. T. (2007) · Haematologica · doi:10.3324/haematol.10148 · Cited by 137
Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment
Krishnan, A. V., & Feldman, D. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0139 · Cited by 139
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
Dong, X., Chu, D., & Wang, Z. (2017) · Theranostics · doi:10.7150/thno.18069 · Cited by 137
Genetic aspects of inflammation and cancer
Hold, G. L., & El-Omar, E. M. (2008) · Biochemical Journal · doi:10.1042/bj20071341 · Cited by 135
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
Kawamura, M., Toiyama, Y., Tanaka, K., Saigusa, S., Okugawa, Y., Hiro, J., Uchida, K., Mohri, Y., Inoue, Y., & Kusunoki, M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.032 · Cited by 136
Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
Quail, D. F., & Joyce, J. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0133 · Cited by 135
[ 177 Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent
Schottelius, M., Osl, T., Poschenrieder, A., Hoffmann, F., Beykan, S., Hänscheid, H., Schirbel, A., Buck, A. K., Kropf, S., Schwaiger, M., et al. (2017) · Theranostics · doi:10.7150/thno.19119 · Cited by 135
Brain Metastases from Colorectal Cancer: Risk Factors, Incidence, and the Possible Role of Chemokines
Mongan, J. P., Fadul, C. E., Cole, B. F., Zaki, B. I., Suriawinata, A. A., Ripple, G. H., Tosteson, T. D., & Pipas, J. M. (2009) · Clinical Colorectal Cancer · doi:10.3816/ccc.2009.n.016 · Cited by 135
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression
López-Lago, M. A., Posner, S., Thodima, V. J., Molina, A. M., Motzer, R. J., & Chaganti, R. S. K. (2012) · Oncogene · doi:10.1038/onc.2012.201 · Cited by 137
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner
Yumimoto, K., Akiyoshi, S., Ueo, H., Sagara, Y., Onoyama, I., Ueo, H., Ohno, S., Mori, M., Mimori, K., & Nakayama, K. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78782 · Cited by 137
mTOR Complex Component Rictor Interacts with PKCζ and Regulates Cancer Cell Metastasis
Zhang, F., Zhang, X., Li, M., Chen, P., Zhang, B., Guo, H. B., Cao, W., Wei, X., Cao, X., Hao, X., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0207 · Cited by 134
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
Khare, T., Bissonnette, M., & Khare, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147371 · Cited by 134
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
Wang, J., Tannous, B. A., Poznansky, M. C., & Chen, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105010 · Cited by 138
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Bartels, K., Horn, C., Stahl, T., Cao, Y. W., Milde‐Langosch, K., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604621 · Cited by 132
Engineering lymph node homing of ex vivo–expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
Somanchi, S. S., Somanchi, A., Cooper, L. J. N., & Lee, D. A. (2012) · Blood · doi:10.1182/blood-2011-11-389924 · Cited by 135
The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T. S., Ogawa, R., Taketo, M. M., & Sakai, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050643 · Cited by 140
Human Melanoma Metastases Express Functional CXCR4
Scala, S., Giuliano, P., Ascierto, P. A., Ieranò, C., Franco, R., Napolitano, M., Ottaiano, A., Lombardi, M. L., Luongo, M., Simeone, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1940 · Cited by 131
The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer
Lin, S., Wang, D., Iyer, S. S., Ghaleb, A. M., Shim, H., Yang, V. W., Chun, J. J. M., & Yun, C. C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.002 · Cited by 130
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis
Tutunea-Fatan, E., Majumder, M., Xin, X., & Lala, P. K. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0306-4 · Cited by 130
Crucial biological functions of CCL7 in cancer
Liu, Y., Cai, Y., Liu, L., Wu, Y., & Xiong, X. (2018) · PeerJ · doi:10.7717/peerj.4928 · Cited by 127
Chemokine Networks and Breast Cancer Metastasis
Karnoub, A. E., & Weinberg, R. A. (2007) · Breast Disease · doi:10.3233/bd-2007-26107 · Cited by 135
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhang, Z., Ni, C., Chen, W., Wu, P., Wang, Z., Yin, J., Huang, J., & Qiu, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-49 · Cited by 129
Obesity and gastrointestinal cancer
Donohoe, C. L., Pidgeon, G. P., Lysaght, J., & Reynolds, J. V. (2010) · British journal of surgery · doi:10.1002/bjs.7079 · Cited by 130
The molecular mechanism of hypertrophic scar
Zhu, Z.-S., Ding, J., Shankowsky, H., & Tredget, E. (2013) · Journal of cell communication and signaling · doi:10.1007/s12079-013-0195-5 · Cited by 124
CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer
Deng, L., Chen, N., Li, Y., Zheng, H. Y., & Lei, Q. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.004 · Cited by 130
Biology and Principles of Scar Management and Burn Reconstruction
Tredget, E. E., Lévi, B., & Donelan, M. B. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.05.005 · Cited by 128
Bruton’s tyrosine kinase (BTK) as a promising target in solid tumors
Molina‐Cerrillo, J., Alonso‐Gordoa, T., Gajate, P., & Grande, E. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.06.001 · Cited by 130
Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase–Dependent Melanoma Cell Invasion
Bartolomé, R. A., Molina‐Ortiz, I., Samaniego, R., Sánchez‐Mateos, P., Bustelo, X. R., & Teixidó, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2489 · Cited by 128
The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
Fan, Y., & He, S. (2022) · Cancer Management and Research · doi:10.2147/cmar.s316700 · Cited by 136
Role of chemokine systems in cancer and inflammatory diseases
Li, H., Wu, M., & Zhao, X. (2022) · MedComm · doi:10.1002/mco2.147 · Cited by 134
Stromal induction of breast cancer: Inflammation and invasion
Radisky, E. S., & Radisky, D. C. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9037-1 · Cited by 125
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
Hu, J., Zhao, Q., Kong, L.-Y., Wang, J., Yan, J., Xia, X., Jia, Z., Heimberger, A. B., & Li, S. (2021) · Science Advances · doi:10.1126/sciadv.abc2511 · Cited by 127
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 148
The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
Grose, R. P., Fantl, V., Werner, S., Chioni, A., Jarosz, M., Rudling, R. J., Cross, B., Hart, I. R., & Dickson, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601583 · Cited by 126
SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
Uygur, B., & Wu, W.-S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-139 · Cited by 126
CXCL8 in Tumor Biology and Its Implications for Clinical Translation
Xiong, X., Liao, X., Qiu, S., Xu, H., Zhang, S., Wang, S., Ai, J., & Yang, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.723846 · Cited by 129
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
Bolitho, C., Hahn, M. A., Baxter, R. C., & Marsh, D. J. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0107 · Cited by 124
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Penticuff, J. C., Woolbright, B. L., Sielecki, T. M., Weir, S. J., & Taylor, J. A. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0171-9 · Cited by 125
Cancer Metabolism Drives a Stromal Regenerative Response
Schwörer, S., Vardhana, S. A., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.015 · Cited by 125
IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling
Lu, J., Song, G., Tang, Q., Zou, C., Han, F., Zhao, Z., Yong, B., Yin, J., Xu, H., Xie, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78437 · Cited by 125
Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4
Manu, K. A., Shanmugam, M. K., Rajendran, P., Li, F., Ramachandran, L., Hay, H. S., Kannaiyan, R., Swamy, S. N., Vali, S., Kapoor, S., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-107 · Cited by 126
Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers
Sharma, M. C. (2018) · International Journal of Cancer · doi:10.1002/ijc.31817 · Cited by 122
Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Song, Y., Huang, Y., Zhou, F., Ding, J., & Zhou, W. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.090 · Cited by 128
A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice
Fang, J., Liang, X., Joo, K., Liu, Y., Zhang, C., Liu, S., Conti, P. S., Li, Z., & Wang, P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29831 · Cited by 126
CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFRβ in Colorectal Carcinoma
Cambien, B., Richard, P., Karimdjee-Soilihi, B., Martini, V., Ferruà, B., Pitard, B., Schmid‐Antomarchi, H., & Schmid‐Alliana, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028842 · Cited by 121
The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells
Ford, A. M., Palmi, C., Bueno, C., Hong, D., Cardus, P., Knight, D., Cazzaniga, G., Enver, T., & Greaves, M. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36428 · Cited by 123
The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery
Russell, J. S., & Brown, J. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00157 · Cited by 122
Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells
Thirunavukkarasan, M., Wang, C., Rao, A., Hind, T., Teo, Y. L., Siddiquee, A. A.-M., Goghari, M. A. I., Kumar, A. P., & Herr, D. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186334 · Cited by 124
Pancreatic Stellate Cells Increase the Invasion of Human Pancreatic Cancer Cells through the Stromal Cell-Derived Factor-1/CXCR4 Axis
Gao, Z., Wang, X., Wu, K., Zhao, Y., & Hu, G. (2010) · Pancreatology · doi:10.1159/000236012 · Cited by 122
The diverse roles of the TNF axis in cancer progression and metastasis.
Ham, B., Fernández, M. C., D'Costa, Z., & Brodt, P. (2016) · PubMed · Cited by 120
CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
Gu, Y., Li, X., Bi, Y., Zheng, Y., Wang, J., Li, X., Huang, Z., Chen, L., Huang, Y., & Huang, Y. (2020) · Aging · doi:10.18632/aging.102656 · Cited by 119
Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy
Hussain, Z., Rahim, M. A., Jan, N., Shah, H., Rawas‐Qalaji, M., Khan, S., Sohail, M. F., Thu, H. E., Ramli, N. A., Sarfraz, R. M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.018 · Cited by 120
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Musella, M., Guarracino, A., Manduca, N., Galassi, C., Ruggiero, E., Potenza, A., Maccafeo, E., Manic, G., Mattiello, L., Rehim, S. S. A., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01290-3 · Cited by 122
Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
Hinton, C. V., Avraham, S., & Avraham, H. K. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9210-2 · Cited by 119
Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma
Liu, J., Li, F., Yü, P., Wang, L., Chen, X., Wang, D., Cao, L., Zhao, S. Q., Li, B., Kaliński, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4617 · Cited by 123
Inflammation and cancer: Till death tears them apart
Raposo, T. P., Beirão, B. C. B., Pang, L. Y., QUEIROGA, F. L., & Argyle, D. J. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2015.04.015 · Cited by 121
MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway
Yu, T., Liu, K., Wu, Y., Fan, J., Chen, J., Li, C., Yang, Q., & Wang, Z. (2013) · Oncogene · doi:10.1038/onc.2013.448 · Cited by 118
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
Heinrich, E. L., Lee, W., Lu, J., Lowy, A. M., & Kim, J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-68 · Cited by 118
Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions
Karagiannis, G. S., Condeelis, J. S., & Oktay, M. H. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1147 · Cited by 116
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Groblewska, M., Litman‐Zawadzka, A., & Mroczko, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103704 · Cited by 121
Comparative analysis of cancer genes in the human and chimpanzee genomes
Puente, X. S., Velasco, G., Gutiérrez‐Fernández, A., Bertranpetit, J., King, M., & López-Otı́n, C. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-15 · Cited by 118
Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells
García-Rivera, D., Delgado, R., Bougarne, N., Haegeman, G., & Vanden Berghe, W. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.011 · Cited by 142
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg, E., Meyrath, M., Milde, L., Herrera, M., Lövrot, J., Hägerstrand, D., Frings, O., Bartish, M., Rolny, C., Sonnhammer, E. L. L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1294 · Cited by 116
CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism
Jamieson, W. L., Shimizu, S., D'Ambrosio, J. A., Meucci, O., & Fatatis, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1315 · Cited by 126
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient
Siddiqui, I., Erreni, M., van Brakel, M., Debets, R., & Allavena, P. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0125-1 · Cited by 118
Copper in cancer: From pathogenesis to therapy
Guan, D., Zhao, L., Shi, X., Ma, X., & Chen, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114791 · Cited by 120
The Role of Immune Cells in the Tumor Microenvironment
Whiteside, T. L. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_5 · Cited by 116
Immune restoration following hematopoietic stem cell transplantation: an evolving target
Auletta, J. J., & Lazarus, H. M. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704966 · Cited by 117

Authors: Balkwill, F.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-07
Volume: 4
Issue: 7
Pages: 540-550
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1388
OpenAlex: W1986986419
Cited by: 2,343
References: 102
Citations by year: 2026: 31 · 2025: 45 · 2024: 57 · 2023: 82 · 2022: 112 · 2021: 132 · 2020: 122 · 2019: 84 · 2018: 131 · 2017: 127 · 2016: 134 · 2015: 133 · 2014: 152 · 2013: 119 · 2012: 135
FWCI: 9.35
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: chemokines, chemokine receptors, carcinogenesis, metastasis, tumor-host interaction, metastatic potential, site-specific metastasis, chemokine receptor antagonists, inflammation, autoimmune disease, cancer therapy
MeSH terms: Animals, Antineoplastic Agents, Autoimmune Diseases, Chemotaxis, Leukocyte, Humans, Inflammation, Macrophage Activation, Mice, Nude, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Lymphocytes, Tumor-Infiltrating, Chemokines, Receptors, Chemokine, Xenograft Model Antitumor Assays, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer and the chemokine network

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks